BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Job Trends

  Moderna to Build “Prototype” Manufacturing Facility in Canada

  Moderna will construct a manufacturing facility in Canada to provide direct access to mRNA vaccines for the COVID-19 pandemic and future viral threats and respiratory viruses.

  August 11, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  FibroGen “Deeply Disappointed” by FDA Rejection of Roxadustat for Anemia of CKD

  The FDA indicated the drug couldn’t be approved in its present form and asked for another clinical trial of the drug be run before they reapplied.

  August 11, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  BioCryst Pharma Cancels Planned Public Offering, Says Funds Are Sufficient

  The global biopharmaceutical company said that it is well capitalized with cash, cash equivalents, restricted cash, and investments of as much as $222.8 million as of 30 June 2021.

  August 11, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  I-Mab’s Antibody for Severe COVID-19 Looks Good in Interim Analysis

  I-Mab announced positive interim data from its U.S. Phase II/III clinical trial of plonmarlimab for treatment of cytokine release syndrome in severe COVID-19.

  August 11, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  Takeda Settles “Pay-for-Delay” Consumer Claims for $1.85 Million

  The settlement is a huge development for the class action lawsuit against Takeda, which has been going on since 2016.

  August 11, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  COVID-19 Vaccination Continues to Lag in Women Who Are Pregnant

  Women who are pregnant are more vulnerable to developing severe illness after infection with SARS-Cov-2, the novel coronavirus that causes COVID-19.

  August 11, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Policy

  Emergent’s Woes Are Dire but Not Insurmountable, Legal Expert Says

  Emergent BioSolutions has approval to resume manufacturing vaccines, but its lawsuit issues haven’t gone away as easily.

  August 11, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Drug Development

  Reify Health Raises $220 Million to Speed Up Clinical Trials and Get Meds to Patients Faster

  Trying to get clinical trials enrolled and completed creates a bottleneck that has hindered drug development for years. With a fresh $220 million in hand, Reify Health is looking to change that.

  August 11, 2021

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Deals

  AbbVie’s Soliton Acquisition Hits a Snag as FTC Increases Scrutiny

  AbbVie’s Allergan Aesthetics announced it was buying Soliton in a deal worth about $550 million. Now, the Federal Trade Commission has requested additional information about the deal.

  August 11, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Plant-Based Biologics All the Rage as Lumen Partners with Google

  The companies will harness the power of machine learning to increase the scalability of medicines based on spirulina, a type of blue-green algae.

  August 11, 2021

   · 

  2 min read

   · 

  Alex Keown